Literature DB >> 17961019

National trends, complications, and outcomes following transsphenoidal surgery for Cushing's disease from 1993 to 2002.

Chirag G Patil1, Shivanand P Lad, Griffith R Harsh, Edward R Laws, Maxwell Boakye.   

Abstract

OBJECT: Information about complications, patient outcomes, and mortality rate after transsphenoidal surgery (TSS) for Cushing's disease has been derived largely from single-institution series. In this study the authors report on inpatient death, morbidity, and outcomes following TSS for Cushing's disease on a national level.
METHODS: All patients in the Nationwide Inpatient Sample (NIS) database who had undergone transsphenoidal resection of a pituitary tumor for Cushing's disease between 1993 and 2002 were included in the study. The number of cases per year, length of stay (LOS), and rates of inpatient complications, death, and adverse outcomes (death or discharge to institution other than home) were abstracted. Univariate and multivariate analyses were performed to determine the effects of patient and hospital characteristics on outcome measures.
RESULTS: According to the NIS, there were an estimated 3525 cases of TSS for Cushing's disease in the US between 1993 and 2002. During this period, there was a trend toward a small increase in the number of TSSs for Cushing's disease. The in-hospital mortality rate was 0.7%, and the complication rate was 42.1%. Diabetes insipidus (15%), fluid and electrolyte abnormalities (12.5%), and neurological deficits (5.6%) were the most common complications reported. Multivariate analysis showed that complications were more likely in patients with pre-operative comorbidities. Patients older than 64 years were much more likely to have an adverse outcome (odds ratio [OR] 20.8) and a prolonged hospital stay (OR 2.2). Women were less likely than men to have an adverse outcome (OR 0.3). A single postoperative complication increased the mean LOS by 3 days, more than tripled the odds of an adverse outcome, and increased the hospital charges by more than US $7000.
CONCLUSIONS: The authors provided a national perspective on trends, inpatient complications, and outcomes after TSS for Cushing's disease in the US. Postoperative complications had a significantly negative effect on LOS, adverse outcome, and resource utilization. Advanced age and multiple preoperative comorbidities were identified as important risk factors, and their effects on patient outcomes were quantified.

Entities:  

Mesh:

Year:  2007        PMID: 17961019     DOI: 10.3171/foc.2007.23.3.9

Source DB:  PubMed          Journal:  Neurosurg Focus        ISSN: 1092-0684            Impact factor:   4.047


  20 in total

Review 1.  Functional Gonadotroph Adenomas: Case Series and Report of Literature.

Authors:  David J Cote; Timothy R Smith; Courtney N Sandler; Tina Gupta; Tejus A Bale; Wenya Linda Bi; Ian F Dunn; Umberto De Girolami; Whitney W Woodmansee; Ursula B Kaiser; Edward R Laws
Journal:  Neurosurgery       Date:  2016-12       Impact factor: 4.654

2.  Incremental healthcare resource utilization and costs in US patients with Cushing's disease compared with diabetes mellitus and population controls.

Authors:  Michael S Broder; Maureen P Neary; Eunice Chang; William H Ludlam
Journal:  Pituitary       Date:  2015-12       Impact factor: 4.107

Review 3.  The Treatment of Cushing's Disease.

Authors:  Rosario Pivonello; Monica De Leo; Alessia Cozzolino; Annamaria Colao
Journal:  Endocr Rev       Date:  2015-06-11       Impact factor: 19.871

4.  OUTCOME OF IMPLEMENTATION OF A MULTIDISCIPLINARY TEAM APPROACH TO THE CARE OF PATIENTS AFTER TRANSSPHENOIDAL SURGERY.

Authors:  Arthur S Carminucci; John C Ausiello; Gabrielle Page-Wilson; Michelle Lee; Laura Good; Jeffrey N Bruce; Pamela U Freda
Journal:  Endocr Pract       Date:  2015-10-05       Impact factor: 3.443

5.  Surgical treatment of prolactinomas: cons.

Authors:  Eve Bloomgarden; Mark E Molitch
Journal:  Endocrine       Date:  2014-08-12       Impact factor: 3.633

6.  Olfactory neuroblastoma following treatment for pituitary adenoma.

Authors:  Kyung-Jae Park; Shin-Hyuk Kang; Hoon-Gab Lee; Yong-Gu Chung
Journal:  J Neurooncol       Date:  2008-08-05       Impact factor: 4.130

7.  Pilot Study on Early Postoperative Discharge in Pituitary Adenoma Patients: Effect of Socioeconomic Factors and Benefit of Specialized Pituitary Centers.

Authors:  Christopher A Sarkiss; James Lee; Joseph A Papin; Eliza B Geer; Rudrani Banik; Janet C Rucker; Barbara Oudheusden; Satish Govindaraj; Raj K Shrivastava
Journal:  J Neurol Surg B Skull Base       Date:  2015-04-27

Review 8.  Pituitary disease mortality: is it fiction?

Authors:  Eva Marie Erfurth; Peter Siesjö; Thomas Björk-Eriksson
Journal:  Pituitary       Date:  2013-09       Impact factor: 4.107

9.  Predictors of mortality and long-term outcomes in treated Cushing's disease: a study of 346 patients.

Authors:  Jessica K Lambert; Levana Goldberg; Sofia Fayngold; Jane Kostadinov; Kalmon D Post; Eliza B Geer
Journal:  J Clin Endocrinol Metab       Date:  2013-02-07       Impact factor: 5.958

10.  Treatment patterns in Cushing's disease patients in two large United States nationwide databases: application of a novel, graphical methodology.

Authors:  Michael S Broder; Maureen P Neary; Eunice Chang; Dasha Cherepanov; Gordon H Sun; William H Ludlam
Journal:  Pituitary       Date:  2015-08       Impact factor: 4.107

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.